Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

electroCore Inc. (ECOR)

  • Business News
  • July 22, 2025, 20:05 UTC
  • 1

electroCore to Participate in Upcoming Investor Conferences

Market reaction Comment Full text

Rhythm Pharmaceuticals Inc (RYTM)

  • Business News
  • July 22, 2025, 20:02 UTC
  • 1

Rhythm Pharmaceuticals to Report Second Quarter 2025 Financial Results on Tuesday, August 5, 2025

Market reaction Comment Full text

Personalis Inc (PSNL)

  • Business News
  • July 22, 2025, 20:02 UTC
  • 1

Personalis to Announce Second Quarter 2025 Financial Results

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • July 22, 2025, 19:46 UTC
  • 1

South Park’s Season 27 Premiere Delayed Amid Landmark $1.5 Billion Streaming Deal

Market reaction Comment Full text

Oncolytics Biotech Inc (ONCY)

  • Business News
  • July 22, 2025, 19:42 UTC
  • 1

A New Press Release from Oncolytics Biotech, Inc

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • July 22, 2025, 19:41 UTC
  • 1

The Mandalorian & Grogu: What’s Next for the Galaxy’s Most Beloved Duo?

Market reaction Comment Full text

Oncolytics Biotech Inc (ONCY)

  • Business News
  • July 22, 2025, 19:32 UTC
  • 1

Oncolytics Biotech® Regains Compliance with Nasdaq Trading Rules

Market reaction Comment Full text

Briacell Therapeutics Corp (BCTX)

  • Business News
  • July 22, 2025, 19:16 UTC
  • 1

Notification from BriaCell Therapeutics Corp.

Market reaction Comment Full text

Replimune Group Inc (REPL)

  • Business News
  • July 22, 2025, 18:56 UTC
  • 1

REPL BREAKING NEWS: Replimune Group, Inc. Stock Plummets 75% after FDA Response Letter – BFA Law Announces Securities Fraud Investigation and Urges Investors to Contact the Firm

Market reaction Comment Full text

Alto Neuroscience Inc. (ANRO)

  • Business News
  • July 22, 2025, 18:46 UTC
  • 1

ANRO Investors Have Opportunity to Lead Alto Neuroscience, Inc. Securities Fraud Lawsuit

Market reaction Comment Full text
  • Previous
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Search

News categories

  • Technical Exchange News(9632)
  • Event(407)
  • SEC News(157950)
  • FDA Approval(9089)
  • Company Report(721)
  • Business News(107209)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin